Think your odds of R&D suc­cess are mis­er­able? MIT’s An­drew Lo might have a sur­prise for you

Maybe the odds of suc­cess in a clin­i­cal tri­al aren’t as mis­er­able as just about every­one in the bio­phar­ma R&D sec­tor as­sumes.

MIT pro­fes­sor An­drew Lo and his team crunched the re­sults on more than 185,000 clin­i­cal tri­als in­volv­ing 21,000 com­pounds — cour­tesy of some new tech­niques in Big Da­ta analy­sis — and found that near­ly 14% of the drugs that make it to the clin­ic ac­tu­al­ly go on to an ap­proval.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.